Centralized Medtech Regulation: Which Way Should The EU Go?

 
• By Amanda Maxwell

Centralized regulation will be beneficial for classification and borderline decisions, orphan device decisions, and recertifying notified bodies. But it is not a panacea for EU medtech in the view of Sabina Hoekstra-van den Bosch.

Silver Bullet
Centralization is not a 'silver bullet' to end EU medtech's problems • Source: Shutterstock

More from Europe

More from Policy & Regulation